{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T15:53:54Z","timestamp":1721922834598},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T00:00:00Z","timestamp":1684713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T00:00:00Z","timestamp":1684713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Martin-Luther-Universit\u00e4t Halle-Wittenberg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In stereotactic radiotherapy, dose is prescribed to an isodose surrounding the planning target volume (PTV). However, the desired dose inhomogeneity inside the PTV leaves the specific dose distribution to the gross tumor volume (GTV) unspecified. A simultaneously integrated boost (SIB) to the GTV could solve this shortcoming. In a retrospective planning study with 20 unresected brain metastases, a SIB approach was tested against the classical prescription.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>For all metastases, the GTV was isotropically enlarged by 3\u00a0mm to a PTV. Two plans were generated, one according to the classical 80% concept with 5 times 7\u00a0Gy prescribed (on D<jats:sub>2%<\/jats:sub>) to the 80% PTV surrounding isodose (with D<jats:sub>98%<\/jats:sub>(PTV)\u2009\u2265\u200935\u00a0Gy), and the other one following a SIB concept with 5 times 8.5\u00a0Gy average GTV dose and with D<jats:sub>98%<\/jats:sub>(PTV)\u2009\u2265\u200935\u00a0Gy as additional requirement. Plan pairs were compared in terms of homogeneity inside GTV, high dose in PTV rim around GTV, and dose conformity and gradients around PTV using Wilcoxon matched pairs signed rank test.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The SIB concept was superior to the classical 80% concept concerning dose homogeneity inside GTV: Heterogeneity index of GTV was in the SIB concept (median 0.0513, range 0.0397\u20130.0757) significantly (p\u2009=\u20090.001) lower than in the 80% concept (median 0.0894, range 0.0447\u20130.1872). Dose gradients around PTV were not inferior. The other examined measures were comparable.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our stereotactic SIB concept better defines the dose distribution inside PTV and can be considered for clinical use.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13014-023-02266-9","type":"journal-article","created":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T12:02:01Z","timestamp":1684756921000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Feasibility of a simultaneously integrated boost concept for hypofractionated stereotactic radiotherapy of unresected brain metastases"],"prefix":"10.1186","volume":"18","author":[{"given":"Christine","family":"Kornhuber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Ensminger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"H\u00fcbsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Janich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris Andre","family":"Leucht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Vordermark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian T.","family":"Dietzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,22]]},"reference":[{"key":"2266_CR1","first-page":"1018","volume":"62","author":"BM Swinson","year":"2008","unstructured":"Swinson BM, Friedman W. Linear accelerator stereotactic radiosurgery for metastatic brain tumors: 17 years of experience at the University of Florida. Neurosurgery. 2008;62:1018\u201331.","journal-title":"Neurosurgery"},{"key":"2266_CR2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S1470-2045(14)70061-0","volume":"15","author":"M Yamamoto","year":"2014","unstructured":"Yamamoto M, Serizawa T, Shuto T, et al. Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol. 2014;15:387\u201395.","journal-title":"Lancet Oncol"},{"key":"2266_CR3","volume":"13","author":"Z Gude","year":"2021","unstructured":"Gude Z, Adamson J, Kirkpatrick JP, Giles W. Hippocampal avoidance in multitarget radiosurgery. Cureus. 2021;13: e15399.","journal-title":"Cureus"},{"key":"2266_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1748-717X-6-48","volume":"6","author":"G Minniti","year":"2011","unstructured":"Minniti G, Clarke E, Lanzetta G, et al. Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis. Radiat Oncol. 2011;6:48.","journal-title":"Radiat Oncol"},{"key":"2266_CR5","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0360-3016(99)00507-6","volume":"47","author":"E Shaw","year":"2000","unstructured":"Shaw E, Scott C, Souhami L, et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90\u201305. Int J Radiat Oncol Biol Phys. 2000;47:291\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2266_CR6","doi-asserted-by":"publisher","first-page":"907","DOI":"10.3171\/jns.2006.104.6.907","volume":"104","author":"MA Vogelbaum","year":"2006","unstructured":"Vogelbaum MA, Angelov L, Lee SY, Li L, Barnett GH, Suh JH. Local control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin. J Neurosurg. 2006;104:907\u201312.","journal-title":"J Neurosurg"},{"key":"2266_CR7","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00066-007-1714-1","volume":"183","author":"A Fahrig","year":"2007","unstructured":"Fahrig A, Ganslandt O, Lambrecht U, et al. Hypofractionated stereotactic radiotherapy for brain metastases\u2013results from three different dose concepts. Strahlenther Onkol. 2007;183:625\u201330.","journal-title":"Strahlenther Onkol"},{"key":"2266_CR8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13014-020-01517-3","volume":"15","author":"L Mengue","year":"2020","unstructured":"Mengue L, Bertaut A, Ngo Mbus L, et al. Brain metastases treated with hypofractionated stereotactic radiotherapy: 8 years experience after Cyberknife installation. Radiat Oncol. 2020;15:82.","journal-title":"Radiat Oncol"},{"key":"2266_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00066-018-1416-x","volume":"195","author":"L Wilke","year":"2019","unstructured":"Wilke L, Andratschke N, Blanck O, et al. ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams: statement from the DEGRO\/DGMP working group stereotactic radiotherapy and radiosurgery. Strahlenther Onkol. 2019;195:193\u20138.","journal-title":"Strahlenther Onkol"},{"key":"2266_CR10","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1007\/s00066-021-01799-w","volume":"197","author":"L Wilke","year":"2021","unstructured":"Wilke L, Moustakis C, Blanck O, et al. Improving interinstitutional and intertechnology consistency of pulmonary SBRT by dose prescription to the mean internal target volume dose. Strahlenther Onkol. 2021;197:836\u201346.","journal-title":"Strahlenther Onkol"},{"key":"2266_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.prro.2019.09.014","volume":"10","author":"DG Tanenbaum","year":"2020","unstructured":"Tanenbaum DG, Buchwald ZS, Jhaveri J, et al. Dosimetric factors related to radiation necrosis after 5-fraction radiosurgery for patients with resected brain metastases. Pract Radiat Oncol. 2020;10:36\u201343.","journal-title":"Pract Radiat Oncol"},{"key":"2266_CR12","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00066-014-0648-7","volume":"190","author":"M Kocher","year":"2014","unstructured":"Kocher M, Wittig A, Piroth MD, Treuer H, Seegenschmiedt H, Ruge M, Grosu AL, Guckenberger M. Stereotactic radiosurgery for treatment of brain metastases. A report of the DEGRO working group on stereotactic radiotherapy. Strahlenther Onkol. 2014;190:521\u201332.","journal-title":"Strahlenther Onkol"},{"key":"2266_CR13","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s00066-018-1349-4","volume":"194","author":"M W\u00f6sle","year":"2018","unstructured":"W\u00f6sle M, Krause L, Sreenivasa S, Vordermark D, Ciernik IF. Stereotactic radiotherapy for choroidal melanomas by means of HybridArc\u2122\u202f: physics and technique of linac-based photon beam therapy. Strahlenther Onkol. 2018;194:929\u201343.","journal-title":"Strahlenther Onkol"},{"key":"2266_CR14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.zemedi.2019.09.002","volume":"30","author":"M W\u00f6sle","year":"2020","unstructured":"W\u00f6sle M. The superficially averaged dose gradient at the target volume\u2019s boundary: a two-dimensional formulation and solution of anisotropic dose gradient problems. Z Med Phys. 2020;30:70\u201386.","journal-title":"Z Med Phys"},{"key":"2266_CR15","volume-title":"Verteilungsfreie methoden in der biostatistik","author":"JLG Bortz","year":"2008","unstructured":"Bortz JLG, Boehnke K. Verteilungsfreie methoden in der biostatistik. 3rd ed. Heidelberg: Springer Medizin Verlag; 2008.","edition":"3"},{"key":"2266_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ijrobp.2020.08.013","volume":"110","author":"MT Milano","year":"2021","unstructured":"Milano MT, Grimm J, Niemierko A, et al. Single-and multifraction stereotactic radiosurgery dose\/volume tolerances of the brain. Int J Radiat Oncol Biol Phys. 2021;110:68\u201386.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2266_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canrad.2020.04.011","volume":"25","author":"L Brun","year":"2021","unstructured":"Brun L, Dupic G, Chassin V, et al. Hypofractionated stereotactic radiotherapy for large brain metastases: optimizing the dosimetric parameters. Cancer Radiother. 2021;25:1\u20137.","journal-title":"Cancer Radiother"},{"key":"2266_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/acm2.12764","volume":"21","author":"D Pokhrel","year":"2020","unstructured":"Pokhrel D, Halfman M, Sanford L. FFF-VMAT for SBRT of lung lesions: improves dose coverage at tumor-lung interface compared to flattened beams. J Appl Clin Med Phys. 2020;21:26\u201335.","journal-title":"J Appl Clin Med Phys"},{"key":"2266_CR19","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s11060-020-03628-z","volume":"149","author":"D Di Perri","year":"2020","unstructured":"Di Perri D, Tanguy R, Malet C, Robert A, Sunyach MP. Risk of radiation necrosis after hypofractionated stereotactic radiotherapy (HFSRT) for brain metastases: a single center retrospective study. J Neurooncol. 2020;149:447\u201353.","journal-title":"J Neurooncol"},{"key":"2266_CR20","doi-asserted-by":"publisher","first-page":"559193","DOI":"10.3389\/fonc.2020.559193","volume":"10","author":"F Putz","year":"2020","unstructured":"Putz F, Weissmann T, Oft D, et al. FSRT vs. SRS in brain metastases\u2014differences in local control and radiation necrosis\u2014a volumetric study. Front Oncol. 2020;10:559193.","journal-title":"Front Oncol"},{"key":"2266_CR21","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3171\/sup.2006.105.7.194","volume":"105","author":"I Paddick","year":"2006","unstructured":"Paddick I, Lippitz B. A simple dose gradient measurement tool to complement the conformity index. J Neurosurg. 2006;105:194\u2013201.","journal-title":"J Neurosurg"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-023-02266-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-023-02266-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-023-02266-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T12:04:58Z","timestamp":1684757098000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-023-02266-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,22]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2266"],"URL":"https:\/\/doi.org\/10.1186\/s13014-023-02266-9","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,22]]},"assertion":[{"value":"7 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study was approved by the Ethics Committee of the Medical Faculty, Martin Luther University Halle-Wittenberg (reference number 2022-093). An informed consent was not required for this planning study on anonymized patient data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"88"}}